185 related articles for article (PubMed ID: 34606022)
1. Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy.
Shimizu R; Honda M; Teraoka S; Yumioka T; Yamaguchi N; Kawamoto B; Iwamoto H; Morizane S; Hikita K; Takenaka A
Int J Clin Oncol; 2022 Jan; 27(1):175-183. PubMed ID: 34606022
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.
Taguchi S; Akamatsu N; Nakagawa T; Gonoi W; Kanatani A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Homma Y
Clin Genitourin Cancer; 2016 Jun; 14(3):237-43. PubMed ID: 26337653
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
Miyake M; Morizawa Y; Hori S; Marugami N; Shimada K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Fujimoto K
BMC Cancer; 2017 Mar; 17(1):237. PubMed ID: 28359307
[TBL] [Abstract][Full Text] [Related]
4. Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy.
Abe H; Takei K; Uematsu T; Tokura Y; Suzuki I; Sakamoto K; Nishihara D; Yamaguchi Y; Mizuno T; Nukui A; Kobayashi M; Kamai T
Int J Clin Oncol; 2018 Apr; 23(2):338-346. PubMed ID: 29098519
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder.
Stangl-Kremser J; D'Andrea D; Vartolomei M; Abufaraj M; Goldner G; Baltzer P; Shariat SF; Tamandl D
Urol Oncol; 2019 Jun; 37(6):372-379. PubMed ID: 30578161
[TBL] [Abstract][Full Text] [Related]
6. Progressive Sarcopenia in Patients With Colorectal Cancer Predicts Survival.
Deng CY; Lin YC; Wu JS; Cheung YC; Fan CW; Yeh KY; McMahon CJ
AJR Am J Roentgenol; 2018 Mar; 210(3):526-532. PubMed ID: 29364725
[TBL] [Abstract][Full Text] [Related]
7. Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
Fukushima H; Kataoka M; Nakanishi Y; Sakamoto K; Takemura K; Suzuki H; Ito M; Tobisu KI; Fujii Y; Koga F
Urol Oncol; 2018 Apr; 36(4):156.e9-156.e16. PubMed ID: 29051030
[TBL] [Abstract][Full Text] [Related]
8. Utility of multidetector computed tomography quantitative measurements in identifying sarcopenia: a propensity score matched study.
Zuo YQ; Gao ZH; Wang Z; Liu Q; Yang X; Yin YL; Feng PY
Skeletal Radiol; 2022 Jun; 51(6):1303-1312. PubMed ID: 34757481
[TBL] [Abstract][Full Text] [Related]
9. Effects of psoas major muscle volume in predicting the prognosis of patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Yuzuriha S; Hasegawa M; Nakajima N; Shimizu Y; Otaki T; Umemoto T; Kawakami M; Kim H; Nitta M; Kawamura Y; Shoji S; Miyajima A
Jpn J Clin Oncol; 2021 Nov; 51(11):1672-1679. PubMed ID: 34363081
[TBL] [Abstract][Full Text] [Related]
10. Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy.
Nagai T; Naiki T; Iida K; Nozaki S; Etani T; Sugiyama Y; Ando R; Yanase T; Chaya R; Moritoki Y; Kobayashi D; Akita H; Okamura T; Yasui T
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2995-3000. PubMed ID: 31653146
[TBL] [Abstract][Full Text] [Related]
11. Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy?
Kocher NJ; Jafri S; Balabhadra S; Lehman E; Gardner J; Vijay K; Sarwani N; Raman JD
Urol Oncol; 2018 Apr; 36(4):156.e17-156.e22. PubMed ID: 29276063
[TBL] [Abstract][Full Text] [Related]
12. A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.
Kasahara R; Kawahara T; Ohtake S; Saitoh Y; Tsutsumi S; Teranishi JI; Miyoshi Y; Nakaigawa N; Yao M; Kobayashi K; Uemura H
Biomed Res Int; 2017; 2017():7981549. PubMed ID: 28497065
[No Abstract] [Full Text] [Related]
13. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
[TBL] [Abstract][Full Text] [Related]
14. The sarcopenia index measured using the lumbar paraspinal muscle is associated with prognosis in endometrial cancer.
Uno K; Yoshikawa N; Kitami K; Mori S; Shibata T; Iyoshi S; Fujimoto H; Mogi K; Yoshihara M; Tamauchi S; Ikeda Y; Yokoi A; Kato K; Hoshiba T; Oguchi H; Kajiyama H
Jpn J Clin Oncol; 2023 Oct; 53(10):942-949. PubMed ID: 37519058
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study.
Ishihara H; Kondo T; Omae K; Takagi T; Iizuka J; Kobayashi H; Hashimoto Y; Tanabe K
Int J Clin Oncol; 2017 Feb; 22(1):136-144. PubMed ID: 27422388
[TBL] [Abstract][Full Text] [Related]
16. Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer.
Rutten IJG; Ubachs J; Kruitwagen RFPM; Beets-Tan RGH; Olde Damink SWM; Van Gorp T
J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):630-638. PubMed ID: 28513088
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
[TBL] [Abstract][Full Text] [Related]
18. Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy.
Ishida T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Mori M; Doki Y
Surgery; 2019 Dec; 166(6):1041-1047. PubMed ID: 31607486
[TBL] [Abstract][Full Text] [Related]
19. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume.
Imai K; Takai K; Watanabe S; Hanai T; Suetsugu A; Shiraki M; Shimizu M
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28937616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
